HLB Therapeutics Statistics

Total Valuation

KOSDAQ:115450 has a market cap or net worth of KRW 797.68 billion. The enterprise value is 826.79 billion.

Market Cap	797.68B
Enterprise Value	826.79B

Important Dates

The next estimated earnings date is Thursday, August 14, 2025.

Earnings Date	Aug 14, 2025
Ex-Dividend Date	n/a

Share Statistics

KOSDAQ:115450 has 83.97 million shares outstanding. The number of shares has increased by 7.43% in one year.

Current Share Class	83.97M
Shares Outstanding	83.97M
Shares Change (YoY)	+7.43%
Shares Change (QoQ)	-10.99%
Owned by Insiders (%)	0.30%
Owned by Institutions (%)	5.20%
Float	73.22M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	13.94
PB Ratio	4.48
P/TBV Ratio	5.58
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-30.16
EV / Sales	14.45
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-185.44

Financial Position

The company has a current ratio of 1.38, with a Debt / Equity ratio of 0.19.

Current Ratio	1.38
Quick Ratio	1.07
Debt / Equity	0.19
Debt / EBITDA	28.00
Debt / FCF	-7.71
Interest Coverage	-1.93

Financial Efficiency

Return on equity (ROE) is -15.45% and return on invested capital (ROIC) is -2.05%.

Return on Equity (ROE)	-15.45%
Return on Assets (ROA)	-1.89%
Return on Invested Capital (ROIC)	-2.05%
Return on Capital Employed (ROCE)	-3.49%
Revenue Per Employee	1.19B
Profits Per Employee	-571.02M
Employee Count	48
Asset Turnover	0.26
Inventory Turnover	8.55

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +34.18% in the last 52 weeks. The beta is -0.53, so KOSDAQ:115450's price volatility has been lower than the market average.

Beta (5Y)	-0.53
52-Week Price Change	+34.18%
50-Day Moving Average	7,955.80
200-Day Moving Average	9,366.69
Relative Strength Index (RSI)	66.23
Average Volume (20 Days)	502,248

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KOSDAQ:115450 had revenue of KRW 57.22 billion and -27.41 billion in losses. Loss per share was -326.67.

Revenue	57.22B
Gross Profit	9.87B
Operating Income	-6.60B
Pretax Income	-27.56B
Net Income	-27.41B
EBITDA	1.23B
EBIT	-6.60B
Loss Per Share	-326.67

Full Income Statement

Balance Sheet

The company has 29.67 billion in cash and 34.37 billion in debt, giving a net cash position of -4.70 billion or -56.03 per share.

Cash & Cash Equivalents	29.67B
Total Debt	34.37B
Net Cash	-4.70B
Net Cash Per Share	-56.03
Equity (Book Value)	178.03B
Book Value Per Share	1,834.74
Working Capital	13.41B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -3.92 billion and capital expenditures -534.16 million, giving a free cash flow of -4.46 billion.

Operating Cash Flow	-3.92B
Capital Expenditures	-534.16M
Free Cash Flow	-4.46B
FCF Per Share	-53.10

Full Cash Flow Statement

Margins

Gross margin is 17.24%, with operating and profit margins of -11.52% and -47.90%.

Gross Margin	17.24%
Operating Margin	-11.52%
Pretax Margin	-48.16%
Profit Margin	-47.90%
EBITDA Margin	2.15%
EBIT Margin	-11.52%
FCF Margin	n/a

Dividends & Yields

KOSDAQ:115450 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-7.43%
Shareholder Yield	n/a
Earnings Yield	-3.44%
FCF Yield	-0.56%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on January 14, 2025. It was a forward split with a ratio of 1.05.

Last Split Date	Jan 14, 2025
Split Type	Forward
Split Ratio	1.05

Scores

KOSDAQ:115450 has an Altman Z-Score of 10.01 and a Piotroski F-Score of 2.

Altman Z-Score	10.01
Piotroski F-Score	2